A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Conditions
T-Cell Leukemia/Lymphoma, Adult · T-cell Leukemia/Lymphoma · T-cell Leukemia · Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Memorial Sloan Kettering at Basking Ridge (All protocol activities), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities), Commack, New York, United States
Memorial Sloan Kettering Westchester (All protocol activities), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Memorial Sloan Kettering Nassau (All protocol activities), Uniondale, New York, United States
Study leads
Steven Horwitz, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center